Bank of America’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-22,877
| Closed | -$205K | – | 7761 |
|
|
2016
Q3 | $205K | Buy |
22,877
+12,099
| +112% | +$86K | ﹤0.01% | 5119 |
|
|
2016
Q2 | $58K | Buy |
+10,778
| New | +$55.3K | ﹤0.01% | 5783 |
|
|
2016
Q1 | – | Sell |
-169,786
| Closed | -$883K | – | 7805 |
|
|
2015
Q4 | $883K | Buy |
169,786
+168,658
| +14,952% | +$979K | ﹤0.01% | 4447 |
|
|
2015
Q3 | $7K | Sell |
1,128
-44,121
| -98% | -$541K | ﹤0.01% | 6697 |
|
|
2015
Q2 | $714K | Buy |
+45,249
| New | +$550K | ﹤0.01% | 4405 |
|
|
2015
Q1 | – | Sell |
-7,516
| Closed | -$79K | – | 8197 |
|
|
2014
Q4 | $79K | Sell |
7,516
-17,325
| -70% | -$169K | ﹤0.01% | 6050 |
|
|
2014
Q3 | $238K | Sell |
24,841
-6,034
| -20% | -$61.6K | ﹤0.01% | 5242 |
|
|
2014
Q2 | $357K | Buy |
30,875
+6,585
| +27% | +$60K | ﹤0.01% | 4959 |
|
|
2014
Q1 | $243K | Buy |
24,290
+6,911
| +40% | +$99.8K | ﹤0.01% | 5266 |
|
|
2013
Q4 | $226K | Buy |
17,379
+14,002
| +415% | +$193K | ﹤0.01% | 5481 |
|
|
2013
Q3 | $51K | Sell |
3,377
-2,973
| -47% | -$35.6K | ﹤0.01% | 6422 |
|
|
2013
Q2 | $59K | Buy |
+6,350
| New | +$43K | ﹤0.01% | 6474 |
|
Bank of America's RPTP Position: Q4 2016 in Review
Bank of America sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 22,877 shares — an estimated $205K sold.
Bank of America first reported a position in RPTP in Q2 2013 and held it in 12 quarters. The position peaked at $883K in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Bank of America reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Bank of America sold 22,877 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $205K.
- Bank of America first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 12 quarters.
- Bank of America's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $883K in Q4 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.